RedixFi
Pre-openNIFTY24,536.6+2.4%
Market feed live

TRUALT · TruAlt Bioenergy Ltd · Chemical Manufacturing

TRUALT · TruAlt Bioenergy Ltd · Chemical Manufacturing

₹363.35-1.6%

As of 05 Nov close

52-week range

52wk low ₹310.252wk high ₹542

33.0% below 52-week high

52-week range: as of 05 Nov 2026 close.

Price chartDaily closes on the stock page.

Stock Condition:Pro

Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.

Full signal detail →

Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old

Operating margin above its own averageFII holding falling for 2+ quartersDebt-to-equity above 1x

Revenue (latest Q)

₹627 Cr

Revenue YoY

PAT YoY

+1108.3%

Operating margin

Revenue, last 8 quarters

P/E (TTM)

P/B

2.5

P/S (TTM)

1.7

Sector P/E

12.5

Dividend yield

0.0%

CompanyP/EP/BNet marginROED/EDiv. yield
TRUALT (this stock)27.62.5+7.2%+9.8%1.090.0%
Asian Paints5311.1+12.8%+22.3%0.18+1.1%
Solar Industries India99.626.6+17.6%+31.4%13.68+0.1%
Pidilite Industries61.319.4+17.2%+24.4%0.04+0.7%

Promoter

stable

FII

falling 3q

MF

6.76% (+0.06pp)

rising 3q

Insider trades

DateInsiderTypeQtyValue
30 Sept 2026NIRANI HOLDINGS PRIVATE LIMITEDBUY1,96,129₹464
28 Sept 2026NIRANI HOLDINGS PRIVATE LIMITEDBUY1,22,032₹5.57 Cr
25 Sept 2026NIRANI HOLDINGS PRIVATE LIMITEDBUY1,52,201₹6.69 Cr
25 Sept 2026KAMALA MURUGESH NIRANISELL3,00,000₹13.17 Cr
22 Sept 2026NIRANI HOLDINGS PRIVATE LIMITEDSELL14,00,000₹58.1 Cr
17 Sept 2026NIRANI HOLDINGS PRIVATE LIMITEDBUY50,000₹2.12 Cr
16 Sept 2026NIRANI HOLDINGS PRIVATE LIMITEDBUY69,575₹2.94 Cr
11 Aug 2026NIRANI HOLDINGS PRIVATE LIMITEDBUY24,200₹1.16 Cr
10 Aug 2026NIRANI HOLDINGS PRIVATE LIMITEDBUY57,801₹2.76 Cr
07 Aug 2026NIRANI HOLDINGS PRIVATE LIMITEDBUY91,705₹4.37 Cr
05 Aug 2026NIRANI HOLDINGS PRIVATE LIMITEDBUY21,600₹1 Cr

Bulk/block deals

canonicalSymboldatebuy quantitybuyer countdeal strengthdeal types present
TRUALT2026-09-234731941STRONGBULK
TRUALT2026-06-087600001STRONGBULK
TRUALT2026-06-0500STRONGBULK
TRUALT2026-06-035905001WEAKBULK

News timeline

No related news.

Concalls & investor presentations

AI-generated
Concall transcriptPositive29 Oct 2026
View source filing →

Key takeaway: TruAlt Bioenergy Limited reported strong revenue growth in Q2 and H1 FY27, with revenue reaching INR811 crores and INR1,438 crores respectively, reflecting a 606% and 243% year-on-year increase. EBITDA improved significantly, with Q2 EBITDA at INR114 crores (14.03% margin) and H1 EBITDA at INR261 crores (18.2% margin), though Q2 margins were pressured by rising raw material costs, particularly maize prices up 25-30%. The company highlighted increased ethanol allocation due to a Supreme Court ruling, raising supply to 40 crore liters for the ethanol supply year. Capacity utilization is expected to rise to 75-80% from 65-70%. In CBG, the company commissioned its first plant and plans to expand with GAIL and Sumitomo, benefiting from GOBARdhan policy incentives. The CFO noted no capex for 1G ethanol but significant CBG capex, with debt expected to be partially offset by subsidies. Working capital concerns were minimal for CBG due to low raw material costs. The company also discussed challenges from El Niño affecting raw material availability and prices, though strategies to stock raw materials at lower prices are in place. Ethanol realization prices dipped slightly to INR64-65 per liter, while DDGS prices rose to INR28-30 per kg. The company emphasized strategic initiatives to improve margins, optimize feedstock, and leverage government incentives for growth.

The document emphasizes strong revenue growth, improved EBITDA, strategic expansions, and government incentives, indicating a positive outlook.

Sourced from an exchange-filed transcript, dated 29 Oct 2026. Summary is RedixFi-generated and distinct from investment advice.

Concall transcriptPositive04 Aug 2026
View source filing →

Key takeaway: During the earnings conference call held on July 29, 2026, management reported a strong performance for the first quarter of FY27, highlighting a revenue of approximately INR 630 crores from ethanol sales, which marked a 106.3% increase from the previous quarter. The company successfully operated three out of five plants at 60% capacity utilization, producing around 8.5 crore litres of ethanol. Management noted plans to increase capacity utilization by an additional 20-25% and mentioned ongoing legal matters that could add 15 crore litres of ethanol capacity. The compressed biogas segment also performed well, generating INR 11 crores in revenue. Management discussed future growth prospects, including the construction of new plants and advancements in sustainable aviation fuel initiatives. The call concluded with management expressing confidence in the company's strategic direction and commitment to enhancing shareholder value.

Management emphasized strong financial performance and growth opportunities.

Sourced from an exchange-filed transcript, dated 04 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationPositive28 Jul 2026
View source filing →

Key takeaway: TruAlt Bioenergy Limited's investor presentation for the quarter ended June 30, 2026, reported significant growth in its operations, with installed ethanol capacity increasing by 43% to 2,000 KLPD. The company highlighted its transition to a dual-feed model, allowing for year-round production and improved profitability. Management noted a strong performance with total income rising to ₹641.41 crore, a 96.37% increase quarter-on-quarter, and a substantial rise in EBITDA and PAT. The presentation emphasized ongoing projects, including a 100 million litres per annum Sustainable Aviation Fuel facility and expansion in the Compressed Biogas segment. Management expressed confidence in the long-term growth potential driven by favorable policies and market conditions, while also addressing the strategic importance of biofuels in India's energy landscape.

Management highlighted strong operational performance and growth opportunities.

Sourced from an exchange-filed presentation, dated 28 Jul 2026. Summary is RedixFi-generated and distinct from investment advice.

Concall transcriptMixed28 May 2026
View source filing →

Key takeaway: On May 22, 2026, TruAlt Bioenergy Limited held its earnings conference call to discuss its audited financial results for the year ended March 31, 2026. Management reported significant transformations, including the commissioning of five ethanol plants and a shift to dual-feed operations in three plants. They noted challenges in the ethanol sector due to a new allocation methodology by oil marketing companies (OMCs), which affected their production capacity and sales. Management highlighted a court ruling in their favor regarding additional ethanol allocations, which remains unimplemented. The company also reported a decline in total income to INR 1,772 crores, attributed to lower tender allocations. However, they indicated improvements in EBITDA margins and ongoing developments in their compressed biogas and sustainable aviation fuel segments. Management emphasized their strategy to diversify revenue streams and reduce dependency on government policies.

Management highlighted both challenges and opportunities in various business segments.

Sourced from an exchange-filed transcript, dated 28 May 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationMixed22 May 2026
View source filing →

Key takeaway: The investor presentation by TruAlt Bioenergy Limited detailed the company's audited financial results for the quarter and year ended March 31, 2026. The presentation highlighted TruAlt's position as the largest ethanol producer in India, with a total installed capacity of 2,000 KLPD, and its strategic initiatives in compressed biogas (CBG) and sustainable aviation fuel (SAF). Management reported challenges in ethanol offtake due to reduced lifting by oil marketing companies, despite operational readiness. The company is advancing its SAF project in Andhra Pradesh and has secured judicial backing for a pending ethanol allocation, which represents significant revenue potential. The presentation emphasized the importance of biofuels in India's energy security amid global geopolitical volatility and outlined the company's disciplined expansion strategy in the retail fuel network. Overall, the document conveyed a commitment to long-term growth and resilience in the evolving bioenergy landscape.

The presentation highlighted both challenges and strategic opportunities in the company's operations.

Sourced from an exchange-filed presentation, dated 22 May 2026. Summary is RedixFi-generated and distinct from investment advice.

Concall transcriptPositive13 Feb 2026
View source filing →

Key takeaway: The earnings conference call held on February 9, 2026, discussed TruAlt Bioenergy Limited's unaudited financial results for the quarter and nine months ended December 31, 2025. Management highlighted the importance of energy independence for India, particularly in the context of global volatility. The company reported significant progress in its ethanol sector, achieving a monthly revenue run rate of approximately INR350-400 crores with capacity utilization exceeding 95% on operational days. The CBG business demonstrated strong financial performance with an EBITDA margin of 63% for the nine months. Management also provided updates on the Sustainable Aviation Fuel (SAF) segment, including a technology licensing agreement with Honeywell UOP and plans for a 100 million liters per annum SAF facility in Andhra Pradesh. Financially, the company reported a total income of INR1,187 crores for the nine months, reflecting a growth of 13.28%. Profit after tax increased to INR35.92 crores, while EBITDA rose to INR170.99 crores.

Management emphasized growth and strategic advancements in multiple business segments.

Sourced from an exchange-filed transcript, dated 13 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationMixed03 Feb 2026
View source filing →

Key takeaway: The investor presentation by TruAlt Bioenergy Limited detailed the company's unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. Management highlighted that TruAlt is the largest ethanol producer in India based on installed capacity and is also a key player in the compressed biogas (CBG) and sustainable aviation fuel (SAF) sectors. The presentation reported a significant increase in total income for Q3 FY26, with a 70% year-over-year growth. However, profit after tax (PAT) showed a decline of 8% compared to the previous quarter. Management noted that all ethanol plants are now fully operational, achieving high capacity utilization rates. The CBG segment demonstrated strong financial performance with an EBITDA margin of 63%. Future plans include expanding the retail fuel network and advancing projects in SAF, supported by strategic partnerships and government incentives. The document emphasized the company's commitment to sustainable energy solutions and long-term growth.

The presentation conveyed both positive growth metrics and challenges in profitability.

Sourced from an exchange-filed presentation, dated 03 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.

AI Summary of Annual Report

AI-generated
FY2025-26359 pages

TruAlt Bioenergy Limited reported a 43.09% decline in Profit After Tax (PAT) for FY2025-26, dropping to ₹8,003 Lakhs from ₹14,061.53 Lakhs in FY2024-25, primarily due to increased finance costs from working capital facilities and depreciation from a new grain-based plant. Consolidated revenue fell 9.45% to ₹1,72,750.66 Lakhs. The Board did not recommend dividends for FY2025-26. The Company faces challenges with delayed revenue from OMCs and pending court-ordered allocations, impacting operations despite readiness. The auditor highlighted ongoing componentization of assets under Ind AS 16, affecting fixed asset register updates. No defaults or insolvency proceedings were noted, and statutory dues were up to date as of March 31, 2026.

  • PAT decreased by 43.09% to ₹8,003 Lakhs in FY2025-26 due to higher finance costs and depreciation.
  • Consolidated revenue declined 9.45% to ₹1,72,750.66 Lakhs.
  • No dividends recommended for FY2025-26 to reinvest profits.
  • Delays in OMC revenue and court-ordered allocations impacted operations.
  • Auditor noted ongoing asset componentization under Ind AS 16, delaying fixed asset register updates.

Key takeaway: TruAlt Bioenergy faces profitability challenges due to increased costs and operational delays, with no dividend distribution and ongoing asset accounting complexities.

The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.

Filed with NSE · 06 Aug 2026View source filing →

Governance disclosures

AI-generated

Needs attention

No item of a kind that needs attention was stored for this company.

Contingent Liability

1 occurrence

Recent (last 12 months)

Annual Report06 Aug 2026 (FY2025-26)
View source filing →

The company provided a corporate guarantee of ₹[amount] on behalf of Trualt Gas Private Limited (a subsidiary) for a loan availed from NABARD, with the loan intended for implementation projects.

Related-Party Transaction

1 occurrence

Recent (last 12 months)

Annual Report06 Aug 2026 (FY2025-26)· 2 passages
View source filing →

The company disclosed that some commercial transactions have taken place with entities where the Company’s Directors hold Directorships. These transactions were approved by the Audit Committee and are considered related party transactions, conducted in the ordinary course of business and on an arm's length basis.

Management & Board Governance

1 occurrence

Recent (last 12 months)

Annual Report06 Aug 2026 (FY2025-26)
View source filing →

The Company has not complied with the requirement of appointing a Woman independent Director as stipulated in the SEBI Listing Regulations for the year ended March 31, 2026.

Promoter Share Pledge

1 occurrence

Recent (last 12 months)

Structured Filing Data (NSE Pledge Disclosure)18 Jul 2026

32.09% of promoter holding pledged (quarter 2026-Q3 as of 2026-07-18).

Open full Signal Dashboard →